APYX vs SSII
APYX: Apyx Medical provides advanced helium plasma-based surgical technology for cosmetic body contouring and hospital-based electrosurgical procedures. SSII: SS Innovations International is a medical technology company specializing in the development and manufacture of robotic-assisted surgical systems.
Side-by-side fundamentals
| Metric | APYX | SSII | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $3.91 | $3.58 | |
| Market cap as of 2026-07-23 | $163M | $716M | |
| Net margin as of 2026-07-23 | -16.4% | -20.7% | APYX higher |
| Gross margin as of 2026-07-23 | +63.1% | +49.1% | APYX higher |
| Operating margin as of 2026-07-23 | -7.7% | -12.6% | APYX higher |
| ROE as of 2026-07-23 | -90.6% | -23.0% | SSII higher |
| ROA as of 2026-07-23 | -14.9% | -13.2% | SSII higher |
| Debt / equity as of 2026-07-23 | 2.74 | 0.20 | SSII lower |
| Revenue growth (YoY) as of 2026-07-23 | +18.2% | +42.6% | SSII higher |
| Revenue CAGR (3y) SEC XBRL | +5.9% | +209.3% | SSII higher |
| Beta as of 2026-07-23 | 1.40 | -78.03 | |
| 1-year return as of 2026-07-22 close | +73.8% | -57.6% | APYX higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.